• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CenterWatch Monthly: September 2006 Issue

CenterWatch Monthly: September 2006 Issue

September 14, 2006
CenterWatch Staff

Hot Latin American Clinical Research Market Will Moderate

Latin America’s clinical research market has experienced significant growth over the past 10 years, especially during the last five. But, the region’s market has grown from a relatively small base and the growth it has experienced in the last five years will not continue at the same rate. Thomson CenterWatch has conducted the first ever survey of sites throughout Latin America, discovering what the bottlenecks for drug development are at the site-level and what sites believe could best prevent future delays.

Addressing the Investigator Shortfall

CenterWatch data show that the widening shortfall of experienced clinical investigators will continue to grow in the U.S. unless sponsors tap into the almost 450,000 physicians who don’t participate in clinical research. The barriers to entry into clinical research conduct are many for U.S. physicians, and some of them are related to the way sponsors select sites. Almost half of physicians surveyed by CenterWatch who do enter the research field and remain involved in trials rank professional development, interest in research and a drive to improve patient care as key motivators.

European Highlights from the 2006 Liquent Regulatory Affairs Trends Survey

Results from the fourth annual Liquent Regulatory Affairs Trends Survey, conducted by Thomson Scientific, generally show that Europeans lag behind non-Europeans in terms of migrating to a completely electronic submission process.

Eye On Thrombosis

If untreated, thrombosis, or formation of a thrombus or blood clot in a vein or artery, may completely block or occlude the affected blood vessel. This prevents blood flow carrying oxygen and nutrients to the tissues normally supplied by that blood vessel, leading to stroke or infarction.

To read the full articles for this issue or for more information on these and other breaking stories, please click here for subscription information.

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • Virtual Doctoer

    Simple Changes Can Make Trials More Patient Friendly

  • Drug approval

    Two-Thirds of Trial Subjects for Drug Approvals Are Outside the U.S.

  • VaccinewithNeedle-360x240.png

    Rules of Vaccine Approval May Be Changing, But Statistical Analysis Tools Remain Constant

  • AskTheExperts-360x240.png

    Ask the Experts: Trial Operations Adjustments in a Remote World

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing